| CDH (n= 19) | CSR (n= 13) | CSA (n= 3) |
---|---|---|---|
Age (years) | 49.4 (29 to 73) | 52.8 (33 to 72) | 69.3 (64 to 74) |
Gender (M:F)*,** | 12:7 | 13:0 | 3:0 |
Number of patients with muscle weakness | 12 (63%) | 9 (69%) | 3 (100%) |
Number of positive Jackson and Spurling tests | 19 (100%) | 11 (85%) | 0 (0%) |
Duration of symptoms (months) | 2.9 (1 to 4) | 3.5 (1 to 12) | 7.0 (1 to 12) |